SRX Health Solutions, Inc.
Here’s whether SRX Health Solutions, Inc. (SRXH) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.
Positives: RSI 54 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-1.89% over 10 days); 3-month momentum negative (-28.5%); rising volume on a downtrend (distribution, 1.44x avg). Currently 93.7% off its 52-week high. Score: -4/7.
SRXH is trading below its 200-day MA ($0.29) — a key warning sign the longer-term trend is under pressure. An RSI of 53.6 sits in the neutral zone — momentum is neither stretched nor exhausted. With ~12 months of trading history, the return since first available bar is -93.5%. The current 93.7% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.